Accretion Pharmaceuticals Limited (NSE:ACCPL)
India flag India · Delayed Price · Currency is INR
67.30
+3.20 (4.99%)
At close: Jan 22, 2026

Accretion Pharmaceuticals Revenue

Accretion Pharmaceuticals had revenue of 219.23M INR in the quarter ending September 30, 2025, with 136.00% growth. This brings the company's revenue in the last twelve months to 826.43M. In the fiscal year ending March 31, 2025, Accretion Pharmaceuticals had annual revenue of 573.76M with 329.70% growth.

Revenue (ttm)
826.43M
Revenue Growth
+329.70%
P/S Ratio
0.86
Revenue / Employee
6.61M
Employees
125
Market Cap
711.98M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025573.76M440.24M329.70%
Mar 31, 2024133.53M-161.79M-54.79%
Mar 31, 2023295.32M69.47M30.76%
Mar 31, 2022225.84M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition